Health Coalition’s Cost-Cutting Pledge Needs Five-Year Target - Orszag
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharma’s eventual role in cost reduction remains unclear; FOBs unlikely to yield savings short-term.